Celltrion Inc 068270

Morningstar Rating
₩213,500.00 −1,000.00 (0.47%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

068270 is trading at a LOCK|vM@x^ premium.
Price
₩214,000.00
Fair Value
LOCK|<&VC.#Sgs@
Uncertainty
LOCK|&tMzn
1-Star Price
LOCK|N<xC.?jBWr<V
5-Star Price
LOCK|$#l^.$<Kvq$
Economic Moat
LOCK|@&L^x
Capital Allocation
LOCK|zWwDd$s

News

Trading Information

Previous Close Price
₩214,500.00
Day Range
₩211,000.00–216,500.00
52-Week Range
₩158,500.00–239,047.62
Bid/Ask
₩213,500.00 / ₩214,000.00
Shares Outstanding
229.16M
Market Cap
₩49.27T
Volume/Avg
89,460 / 496,030

Key Statistics

Price/Earnings (Normalized)
31.77
Price/Sales
10.17
Dividend Yield (Trailing)
0.33%
Dividend Yield (Forward)
0.33%
Dividend Payment Schedule
Apr
Total Yield
1.33%

Company Profile

Celltrion Inc is a biopharmaceutical company that focuses on the research, development, and manufacture of biosimilars and novel biopharmaceuticals. The company's operating segments include Biopharmaceuticals and Chemical medicine segment. Its Biopharmaceuticals segment includes products and commodities such as biopharmaceutical drugs and related product-support services. The Chemical Medicine segment covers products and commodities including various chemical medicines. It generates the majority of its revenue from the Biopharmaceuticals segment.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Large Growth
Total Number of Employees
2,916

Valuation

Metric
068270
Price/Earnings (Normalized)
31.77
Price/Book Value
2.78
Price/Sales
10.17
Price/Cash Flow
29.20
Price/Earnings
068270

Financial Strength

Metric
068270
Quick Ratio
0.74
Current Ratio
1.36
Interest Coverage
19.84
Quick Ratio
068270

Profitability

Metric
068270
Return on Assets (Normalized)
6.47%
Return on Equity (Normalized)
8.46%
Return on Invested Capital (Normalized)
7.21%
Return on Assets
068270

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|T^>RL@LOCK|c$VR>$136B
Regeneron Pharmaceuticals Inc
REGN
LOCK|Bd<@FS&LOCK|<@@%$99B
Moderna Inc
MRNA
LOCK|Sm!K<<ZLOCK|rQ$87B
argenx SE ADR
ARGX
LOCK|>&&W@PgLOCK|!^$61B
BeOne Medicines Ltd ADR
ONC
LOCK|?WD>#qLOCK|>$j$48B
Royalty Pharma PLC Class A
RPRX
LOCK|NtGTK@<LOCK|lfnR>$31B
Incyte Corp
INCY
LOCK|%xK!f%LOCK|bk$25B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|jmG%%FLOCK|#@DD$21B
BioNTech SE ADR
BNTX
LOCK|N>@zQXLOCK|kL&$21B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|Cyp@JN?LOCK|VN?$15B

Sponsor Center